MedPath

Charing Cross Hospital

🇬🇧United Kingdom
Ownership
-
Established
1818-01-01
Employees
-
Market Cap
-
Website
https://www.imperial.nhs.uk/our-locations/charing-cross-hospital

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer

Phase 3
Conditions
Breast Cancer
First Posted Date
2007-08-15
Last Posted Date
2013-08-07
Lead Sponsor
Charing Cross Hospital
Target Recruit Count
1000
Registration Number
NCT00516425
Locations
🇬🇧

Charing Cross Hospital, London, England, United Kingdom

🇬🇧

Southend University Hospital NHS Foundation Trust, Westcliff-On-Sea, England, United Kingdom

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.